19778190

Source:http://linkedlifedata.com/resource/pubmed/id/19778190

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0086728, umls-concept:C0205178, umls-concept:C0439849, umls-concept:C0700359
pubmed:issue	8
pubmed:dateCreated	2009-9-25
pubmed:abstractText	The effects of obidoxime in the treatment of organophosphate poisoning were assessed by biochemical and biological effect monitoring. In this article we report effects on neuromuscular function, oxime and atropine concentration, and relate them to acetylcholinesterase (AChE) activity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101241654
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholinesterase, http://linkedlifedata.com/resource/pubmed/chemical/Antidotes, http://linkedlifedata.com/resource/pubmed/chemical/Atropine, http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Reactivators, http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterases, http://linkedlifedata.com/resource/pubmed/chemical/Dimethoate, http://linkedlifedata.com/resource/pubmed/chemical/Obidoxime Chloride, http://linkedlifedata.com/resource/pubmed/chemical/Organothiophosphorus Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Parathion, http://linkedlifedata.com/resource/pubmed/chemical/methyl demeton
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1556-9519
pubmed:author	pubmed-author:EyerFlorianF, pubmed-author:EyerPeterP, pubmed-author:FelgenhauerNorbertN, pubmed-author:ThiermannHorstH, pubmed-author:WorekFranzF, pubmed-author:ZilkerThomasT
pubmed:issnType	Electronic
pubmed:volume	47
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	807-13
pubmed:dateRevised	2009-11-17
pubmed:meshHeading	pubmed-meshheading:19778190-Acetylcholinesterase, pubmed-meshheading:19778190-Acute Disease, pubmed-meshheading:19778190-Antidotes, pubmed-meshheading:19778190-Atropine, pubmed-meshheading:19778190-Cholinesterase Inhibitors, pubmed-meshheading:19778190-Cholinesterase Reactivators, pubmed-meshheading:19778190-Cholinesterases, pubmed-meshheading:19778190-Dimethoate, pubmed-meshheading:19778190-Drug Administration Schedule, pubmed-meshheading:19778190-Drug Monitoring, pubmed-meshheading:19778190-Erythrocytes, pubmed-meshheading:19778190-Germany, pubmed-meshheading:19778190-Humans, pubmed-meshheading:19778190-Intensive Care, pubmed-meshheading:19778190-Neuromuscular Junction, pubmed-meshheading:19778190-Obidoxime Chloride, pubmed-meshheading:19778190-Organothiophosphorus Compounds, pubmed-meshheading:19778190-Overdose, pubmed-meshheading:19778190-Parathion, pubmed-meshheading:19778190-Suicide, pubmed-meshheading:19778190-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships.
pubmed:affiliation	Bundeswehr Institute of Pharmacology and Toxicology, Sanitätsakademie der Bundeswehr, Munich, Germany.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study